We expect that litigation involving these and other provisions of the IRA will continue, with unpredictable and uncertain results. We further cannot predict with certainty what impact the IRA or any other federal or state health reforms will have on us, but such changes could impose new or more stringent regulatory requirements on our activities or result in reduced reimbursement for our products, any of which could adversely affect our business, results of operations and financial condition. There may be additional Congressional and administrative efforts to address drug pricing.
All entries for: Sage Therapeutics - Cambridge
July 30, 2025
Sage Therapeutics - Cambridge
Negative Outlook
Cambridge, MA
1-50 employees
Disease Area: Multiple, Neurological Diseases, Psychiatry
Drug Type: Small Molecule
April 29, 2025
Sage Therapeutics - Cambridge
Negative Outlook
Cambridge, MA
1-50 employees
We further cannot predict with certainty what impact the IRA or any other federal or state health reforms will have on us, but such changes could impose new or more stringent regulatory requirements on our activities or result in reduced reimbursement for our products, any of which could adversely affect our business, results of operations and financial condition. There may be additional Congressional and administrative efforts to address drug pricing.
Disease Area: Multiple, Neurological Diseases, Psychiatry
Drug Type: Small Molecule